1 INTRODUCTION
1.1 MARKET SEGMENTATION
2 RESEARCH METHODOLOGY
2.1 ECOSYSTEM OF BIOTECHNOLOGY REAGENTS MARKET
2.2 TOP-DOWN APPROACH
2.3 BOTTOM-UP APPROACH
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 GLOBAL BIOTECHNOLOGY REAGENTS MARKET SNAPSHOT
3.2 GLOBAL BIOTECHNOLOGY REAGENTS MARKET REVENUE, 2017 – 2025 (US$ BN)
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 KEY TRENDS ANALYSIS
4.3 TECHNOLOGY DEVELOPMENT AND DIVERSIFICATION ANALYSIS
4.4 PORTERS FIVE FORCE ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 COMPETITIVE LANDSCAPE
4.7 COMPANY MARKET SHARE ANALYSIS, %, 2017
4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS
5 BIOTECHNOLOGY REAGENTS MARKET, BY TECHNOLOGY
5.1 OVERVIEW
5.2 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR LIFE SCIENCE REAGENTS MARKET, VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
5.3 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR ANALYTICAL REAGENTS MARKET, VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
6 BIOTECHNOLOGY REAGENTS MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR DNA & RNA ANALYSIS, VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
6.3 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR, GENE EXPRESSION VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
6.4 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR DRUG TESTING, VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
6.5 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR, PROTEIN SYNTHESIS & EXPRESSION VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
7 BIOTECHNOLOGY REAGENTS MARKET, BY END-USER
7.1 OVERVIEW
7.2 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR, RESEARCH INSTITUTES VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
7.3 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR, BIOTECH COMPANIES VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
7.4 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR, PHARMACEUTICALS VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
7.5 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR, DIAGNOSTIC CENTERS, VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
8 BIOTECHNOLOGY REAGENTS MARKET, BY GEOGRAPHY
8.1 NORTH AMERICA
8.1.1 MARKET DYNAMICS
8.1.1.1 Drivers
8.1.1.2 Restraints
8.1.1.3 Opportunity
8.1.2 U.S.
8.1.3 CANADA
8.1.4 MEXICO
8.2 EUROPE
8.2.1 MARKET DYNAMICS
8.2.1.1 Drivers
8.2.1.2 Restraints
8.2.1.3 Opportunity
8.2.2 U.K.
8.2.3 ITALY
8.2.4 FRANCE
8.2.5 GERMANY
8.2.6 RUSSIA
8.2.7 SPAIN
8.2.8 REST OF EUROPE
8.3 ASIA PACIFIC
8.3.1 MARKET DYNAMICS
8.3.1.1 Drivers
8.3.1.2 Restraints
8.3.1.3 Opportunity
8.3.2 INDIA
8.3.3 CHINA
8.3.4 JAPAN
8.3.5 AUSTRALIA
8.3.6 REST OF ASIA PACIFIC
8.4 MIDDLE EAST AND AFRICA
8.4.1 MARKET DYNAMICS
8.4.1.1 Drivers
8.4.1.2 Restraints
8.4.1.3 Opportunity
8.4.2 GCC
8.4.3 SOUTH AFRICA
8.4.4 REST OF MIDDLE EAST AND AFRICA
8.5 LATIN AMERICA
8.5.1 MARKET DYNAMICS
8.5.1.1 Drivers
8.5.1.2 Restraints
8.5.1.3 Opportunity
8.5.2 BRAZIL
8.5.3 REST OF LATIN AMERICA
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 NEW TECHNOLOGY LAUNCHES
10  BIOTECHNOLOGY REAGENTS MARKET, BY COMPANY
10.1 INTRODUCTION
10.2 AGILENT TECHNOLOGIES INC.
10.2.1 BUSINESS OVERVIEW
10.2.2 TECHNOLOGYS & SERVICES
10.2.3 KEY STRATEGY
10.2.4 RECENT DEVELOPMENTS
10.2.5 SWOT ANALYSIS
10.2.6 OUR COMPANY VIEW
10.3 ABBOTT LABORATORIES
10.3.1 BUSINESS OVERVIEW
10.3.2 TECHNOLOGYS & SERVICES
10.3.3 KEY STRATEGY
10.3.4 RECENT DEVELOPMENTS
10.3.5 SWOT ANALYSIS
10.3.6 OUR COMPANY VIEW
10.4 ANAVEX LIFE SCIENCES CORP.
10.4.1 BUSINESS OVERVIEW
10.4.2 TECHNOLOGYS & SERVICES
10.4.3 KEY STRATEGY
10.4.4 RECENT DEVELOPMENTS
10.4.5 SWOT ANALYSIS
10.4.6 OUR COMPANY VIEW
10.5 BECKMAN COULTER INC.
10.5.1 BUSINESS OVERVIEW
10.5.2 TECHNOLOGYS & SERVICES
10.5.3 KEY STRATEGY
10.5.4 RECENT DEVELOPMENTS
10.5.5 SWOT ANALYSIS
10.5.6 OUR COMPANY VIEW
10.6 BIO-TECHNE CORPORATION
10.6.1 BUSINESS OVERVIEW
10.6.2 TECHNOLOGYS & SERVICES
10.6.3 KEY STRATEGY
10.6.4 RECENT DEVELOPMENTS
10.6.5 SWOT ANALYSIS
10.6.6 OUR COMPANY VIEW
10.7 BECTON, DICKINSON (BD)
10.7.1 BUSINESS OVERVIEW
10.7.2 TECHNOLOGYS & SERVICES
10.7.3 KEY STRATEGY
10.7.4 RECENT DEVELOPMENTS
10.7.5 SWOT ANALYSIS
10.7.6 OUR COMPANY VIEW
10.8 BIO-RAD LABORATORIES
10.8.1 BUSINESS OVERVIEW
10.8.2 TECHNOLOGYS & SERVICES
10.8.3 KEY STRATEGY
10.8.4 RECENT DEVELOPMENTS
10.8.5 SWOT ANALYSIS
10.8.6 OUR COMPANY VIEW
10.9 BIOMERIEUX S.A
10.9.1 BUSINESS OVERVIEW
10.9.2 TECHNOLOGYS & SERVICES
10.9.3 KEY STRATEGY
10.9.4 RECENT DEVELOPMENTS
10.9.5 SWOT ANALYSIS
10.9.6 OUR COMPANY VIEW
10.10 BIOTIME INC.
10.10.1 BUSINESS OVERVIEW
10.10.2 TECHNOLOGYS & SERVICES
10.10.3 KEY STRATEGY
10.10.4 RECENT DEVELOPMENTS
10.10.5 SWOT ANALYSIS
10.10.6 OUR COMPANY VIEW
10.11 C.B.S. SCIENTIFIC COMPANY INC.
10.11.1 BUSINESS OVERVIEW
10.11.2 TECHNOLOGYS & SERVICES
10.11.3 KEY STRATEGY
10.11.4 RECENT DEVELOPMENTS
10.11.5 SWOT ANALYSIS
10.11.6 OUR COMPANY VIEW
10.12 CYANO BIOTECH GMBH
10.12.1 BUSINESS OVERVIEW
10.12.2 TECHNOLOGYS & SERVICES
10.12.3 KEY STRATEGY
10.12.4 RECENT DEVELOPMENTS
10.12.5 SWOT ANALYSIS
10.12.6 OUR COMPANY VIEW
10.13 GE HEALTHCARE
10.13.1 BUSINESS OVERVIEW
10.13.2 TECHNOLOGYS & SERVICES
10.13.3 KEY STRATEGY
10.13.4 RECENT DEVELOPMENTS
10.13.5 SWOT ANALYSIS
10.13.6 OUR COMPANY VIEW
10.14 INVIVOSCRIBE TECHNOLOGIES INC.
10.14.1 BUSINESS OVERVIEW
10.14.2 TECHNOLOGYS & SERVICES
10.14.3 KEY STRATEGY
10.14.4 RECENT DEVELOPMENTS
10.14.5 SWOT ANALYSIS
10.14.6 OUR COMPANY VIEW
10.15 LONZA GROUP LTD.
10.15.1 BUSINESS OVERVIEW
10.15.2 TECHNOLOGYS & SERVICES
10.15.3 KEY STRATEGY
10.15.4 RECENT DEVELOPMENTS
10.15.5 SWOT ANALYSIS
10.15.6 OUR COMPANY VIEW
10.16 LIFE TECHNOLOGIES CORP. (THERMO FISHER)
10.16.1 BUSINESS OVERVIEW
10.16.2 TECHNOLOGYS & SERVICES
10.16.3 KEY STRATEGY
10.16.4 RECENT DEVELOPMENTS
10.16.5 SWOT ANALYSIS
10.16.6 OUR COMPANY VIEW
10.17 MERIDIAN BIOSCIENCES, INC.
10.17.1 BUSINESS OVERVIEW
10.17.2 TECHNOLOGYS & SERVICES
10.17.3 KEY STRATEGY
10.17.4 RECENT DEVELOPMENTS
10.17.5 SWOT ANALYSIS
10.17.6 OUR COMPANY VIEW
10.18 PERKINELMER
10.18.1 BUSINESS OVERVIEW
10.18.2 TECHNOLOGYS & SERVICES
10.18.3 KEY STRATEGY
10.18.4 RECENT DEVELOPMENTS
10.18.5 SWOT ANALYSIS
10.18.6 OUR COMPANY VIEW
10.19 ROCHE
10.19.1 BUSINESS OVERVIEW
10.19.2 TECHNOLOGYS & SERVICES
10.19.3 KEY STRATEGY
10.19.4 RECENT DEVELOPMENTS
10.19.5 SWOT ANALYSIS
10.19.6 OUR COMPANY VIEW
10.20 SIGNALCHEM
10.20.1 BUSINESS OVERVIEW
10.20.2 TECHNOLOGYS & SERVICES
10.20.3 KEY STRATEGY
10.20.4 RECENT DEVELOPMENTS
10.20.5 SWOT ANALYSIS
10.20.6 OUR COMPANY VIEW